Skip to main content

Quanticyt

Objective



Research and development of a clinical tool for the early detection and follow-up of patients with superficial transitional cell carcinoma of the bladder.

Coordinator

Vervain BV
Address
3,Tsjerkepaed
9138 Sn Niawier
Netherlands

Participants (3)

Bioprocon Medical BV
Netherlands
Address
118,Toernooiveld
6525 EC Nijmegem
CellPath Plc
United Kingdom
Address
Leverstock Green Road
HP3 8QE Hemel Hempstead
Vogel GmbH & Co. KG
Germany
Address
81,Marburger Straße
35340 Giessen